Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
ASND compared with BCAX: revenue, margins and what each company keeps, and the suppliers and customers both name
ASND
Ascendis Pharma A/S
Change
Mkt cap
Revenue
Revenue
BCAX
Bicara Therapeutics Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
ASND
Ascendis Pharma A/S
vs
BCAX
Bicara Therapeutics Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Supply-chain overlap
Desk
News
Calendar
Saved
Search
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only ASND
3
NVO
Novo Nordisk A/S
customer
—
Teijin
unlisted
customer
—
VISEN Pharmaceuticals
unlisted
customer
Shared
0
No shared counterparties.
Only BCAX
2
MSD
MSD International GmbH and MSD International Business GmbH
supplier
—
Biocon
unlisted
supplier
Role chip = supplier or customer
—
= no ticker (unlisted)
Source: SEC EDGAR
ASND
Ascendis Pharma A/S
Change
251.32
▲
+0.02%
Mkt cap
$15.6B
BCAX
Bicara Therapeutics Inc.
Change
8.45
▼
−7.50%
Regular session
Nov 2 '26
Mkt cap
$620.2M
vs
Compare
Regular session
Nov 2 '26
ASND
Ascendis Pharma A/S
vs
BCAX
Bicara Therapeutics Inc.
251.32
▲
+0.02%
Price
8.45
▼
−7.50%
$15.6B
Mkt cap
$620.2M
Change
Change
ASND
251.32
▲
+0.02%
vs
BCAX
8.45
▼
−7.50%
Regular session
Nov 2 '26